Related to this topic: Support | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Neuroblastomas

Description
  • Neuroblastoma is an embryonal neoplasm and is predominantly a disease of early childhood.1
  • Other than brain tumours it is the most common solid tumour of childhood and is currently responsible for the highest number of disease related deaths in pre-school age children.2
  • The neuroblastoma originates from sympathetic nervous tissue most commonly in the adrenal or paraspinal sites.
  • Metastases are present in approximately 60% at the time of diagnosis.
Epidemiology
  • Less than 100 children are diagnosed with neuroblastoma each year in the UK.
  • 90% of those diagnosed are under the age of 5 with a peak age of incidence of 2-3.3
  • The aetiology is unknown, but is thought that some may have a genetic predisposition with chromosome 1 or chromosome 16 being the most likely source.4
  • 60% of cases present in children under the age of five and it is even occasionally diagnosed pre-natally on ultrasound scan.5
Presentation6

Presentation is usually quite late and the majority of symptoms and signs occur either due to the mass effect of the tumour or as a result of metastases.

Symptoms

  • Loss of appetite
  • Occasionally watery diarrhoea due to vaso-active intestinal polypeptide (VIP)secretion
  • Vomiting
  • Weight loss
  • Fatigue
  • Bruising due to pancytopenia as a result of marrow infiltration
  • Periorbital bruising - "racoon eyes" (due to metastatic disease in the orbits)
  • Weakness, limping, paralysis and bladder and bowel dysfunction due to spinal cord compression from paraspinal sympathetic tumours
  • Bone pain (due to bone metastases)
  • Cerebellar ataxia and myoclonus - rare
  • Permanent cognitive deficits - rare

Signs

  • Mild fever
  • Abdominal distension due to enlarged liver
  • Hypertension - due to pressure on the renal artery
  • Horner's syndrome due to thoracic lesion
  • Primary cervical neuroblastoma is rare but may result in a mass in the neck
  • "Blueberry muffin baby" - occurs in neonates, metastases cause severe skin involvement, results in a characteristic appearance
Differential Diagnosis6

The differential diagnosis includes other tumours of early childhood such as :

Depending on presentation, other conditions that may need to be considered include:

  • Osteomyelitis
  • Rheumatoid arthritis
  • Disseminated bone disease
  • Primary neurologic disease
  • Inflammatory bowel disease
Investigations7

Laboratory Tests

  • Full blood count - this may detect anaemia.
  • ESR may be raised.
  • Coagulation tests -
    • Prothrombin time and partial thrombopolastin time may be abnormal once liver involvement occurs.
    • Thrombocytopaenia may occur when once deposits overwhelm the bone marrow.
    • Catecholamine by-products can be detected in the urine of patients with neuroblastoma. These include:
  • Homovanillic acid (HVA) and vanillylmandelic acid (VMA). A low VMA-to-HVA ratio is consistent with a poorly differentiated tumour and indicative of a poor prognosis.
  • Neuron-specific enolase (NSE) - elevated levels can be demonstrated in 96% of patients with metastases, indicating a poor prognosis.

Radio-Imaging

  • Plain abdominal X-ray may be a useful initial screening test for any child with an abdominal mass.
  • Ultrasound will help to further assess the site and size of of any intra-abdominal tumour and any abnormalities of the urogenital tract. Small flecks of calcification may be seen in the abdomen or posterior mediastinum.
  • MRI and CT scanning may add further information regarding is the site of primary or secondary tumours.
  • Bone scan may be used to assess secondary lesions. A compound called metaiodobenzylguanidine (MIBG) is taken up specifically by catecholaminergic cells and can help to detect metastatic disease in bones as well as soft tissue. If this is negative but metastases are clinically suspected, technetium bone scan may be helpful.

Procedures

Biopsy of the lesion or of deposits in bone marrow are necessary in order to make a definitive diagnosis.
For an unequivocal diagnosis the following must apply:

  • Light microscopy of tumour biopsy samples, with or without electron microscopy plus increased catecholamine levels or immunohistology.
  • Identification of tumour cells from bone marrow aspirate and increased levels of serum or urinary catecholamines.
Staging6

The International Neuroblastoma Staging System (INSS) has been developed as a prognostic and research tool. Localised tumours are divided into stages 1,2 and 3 according to regional lymph node involvement and whether the tumour infiltrates across the midline or is resectable. All patients over the age of 1 with distant involvement are categorised as stage 4.

Management

Non-Drug

Families with an affected child will need long term support and may benefit from referral to specialist nurses e.g. Macmillan nurses.

Drug7

  • Plasmapheresis and intravenous gammaglobulin may be useful, especially in some cases with eye involvement (opisclonus/myoclonus syndrome).8,9
  • Chemotherapy is used in inoperable cases or as an adjunct to surgery or radiotherapy. Various combinations of agents have been tried, of which the commonest are carboplatin, cyclophosphamide, doxorubicin and etoposide. The duration of treatment can vary from 6 to 24 weeks. More severe cases (25-30% survival) may also be treated with high dose cisplatin and ifosfamide in addition to this regime.
  • Adrenocortical hormone (ACTH) is sometimes useful in controlling symptoms and has even been implicated in some cases of 'spontaneous' remission.10
  • Other therapies currently being investigated include biological response modifiers, anti-angiogenesis agents which inhibit blood vessel growth in the more vascular neuroblastomas, and targeted immunotherapy.

Surgery7

  • Surgical removal of the tumour alone may be used in some low risk tumours (90% survival), but more commonly surgery is combined with chemotherapy.
  • An initial laparotomy is usually performed, to determine an accurate diagnosis, remove all of the primary tumor, and provide accurate staging.
  • A further operation is often performed to remove residual disease.
Complications

Complications at presentation

  • Cord compression from paraspinal tumour
  • Severe hypertension
  • Renal insufficiency

Complications during or after chemotherapy

Surgical complications

Prognosis7
  • The prognosis varies with the age of the patient, the site of the primary, the stage of the disease, lymph node involvement and the tumour histology.
  • Children of any age with localised disease, and children under the age of 1 at presentation with advanced disease tend to respond well to treatment and may have prolonged disease free periods. Older children with advanced disease may have a 2 year survival rate of 20% despite aggressive chemotherapy.
  • Neuroblastoma in adolescence or adulthood has a more prolonged course, 50 % achieving a minimal disease state with aggressive chemotherapy, but the long term prognosis remains poor. A few lesions will spontaneously regress or mature into benign lesions.
  • It is hoped that further work on the histopathological types of neuroblastoma, the genetic factors and governing tumour growth and the biological markers produced by such genetic aberration will help to refine the determination of prognosis in individual patients.12,13

Document References
  1. Kushner BH; Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004 Jul;45(7):1172-88. [abstract]
  2. Grovas A, Fremgen A, Rauck A, et al; The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997 Dec 15;80(12):2321-32. [abstract]
  3. Neuroblastoma; Cancerbackup
  4. Maris JM, Weiss MJ, Mosse Y, et al; Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res. 2002 Nov 15;62(22):6651-8. [abstract]
  5. Penn State Children's Hospital; Neuroblastoma
  6. Lacayo N Neyssa M, Neuroblastoma eMedicine.com 2006
  7. Joyner B; Neuroblastoma eMedicine.com 2006
  8. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, et al; Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics. 2002 Jan;109(1):86-98. [abstract]
  9. Russo C, Cohn SL, Petruzzi MJ, et al; Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Apr;28(4):284-8. [abstract]
  10. Tucker GR; Adrenocorticotropic hormone in the aetiology and regression of neuroblastoma. Med Hypotheses. 2002 Aug;59(2):117-28. [abstract]
  11. Ikeda A, Sakamoto K; Tumor Lysis Syndrome eMedicine.com 2006
  12. Shimada H, Stram DO, Chatten J, et al; Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst. 1995 Oct 4;87(19):1470-6. [abstract]
  13. Abe M, Westermann F, Nakagawara A, et al; Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas. Cancer Lett. 2006 Jun 4;. [abstract]
Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1711
Document Version: 20
DocRef: bgp525
Last Updated: 25 Oct 2006
Review Date: 24 Oct 2008






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page